Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Post-Transplant Complications

Gastric emptying after autologous haemopoietic stem-cell transplantation: a prospective trial

Summary:

Gastroparesis may be involved in the pathophysiology of prolonged nausea and vomiting after haemopoietic stem-cell transplantation (HSCT), but this has not been prospectively investigated. Gastric emptying (GE) was investigated in 20 patients before and 2 months after autologous HSCT. Gastrointestinal symptoms were graded prospectively and oral energy intake was recorded in parallel. Before transplant, all patients were asymptomatic and GE was within the reference range. Post transplant GE was delayed in three patients and three patients reported nausea and/or vomiting. Neither gastrointestinal symptoms nor oral energy intake post transplant discriminated between patients with or without delayed GE. Oral energy intake before transplant was lower (P=0.05), and there was a greater need for total parenteral nutrition (TPN) among patients who developed gastroparesis post transplant (P<0.05).

Delayed GE after HSCT was found to be less common than had been believed from retrospective studies. Gastroparesis may be involved in some cases of prolonged nausea and vomiting after autologous HSCT but alternative explanations should be considered. Symptoms consistent with gastroparesis did not correlate with GE. Patients at risk of developing gastroparesis may be found among those with nutritional difficulties before and during the transplant course.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Snyder DS, Negrin RS, O'Donnell MR et al. Fractionated total-body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 94 patients with chronic myelogenous leukemia in chronic phase. Blood 1994; 84: 1672–1679.

    CAS  PubMed  Google Scholar 

  2. Zittoun RA, Mandelli F, Willemze R et al. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups [see comments]. N Engl J Med 1995; 332: 217–223.

    Article  CAS  Google Scholar 

  3. Snyder DS, Nademanee AP, O'Donnell MR et al. Long-term follow-up of 23 patients with Philadelphia chromosome- positive acute lymphoblastic leukemia treated with allogeneic bone marrow transplant in first complete remission. Leukemia 1999; 13: 2053–2058.

    Article  CAS  Google Scholar 

  4. Childs R, Chernoff A, Contentin N et al. Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation [see comments]. N Engl J Med 2000; 343: 750–758.

    Article  CAS  Google Scholar 

  5. Nichols CR, Andersen J, Lazarus HM et al. High-dose carboplatin and etoposide with autologous bone marrow trans- plantation in refractory germ cell cancer: an Eastern Coopera-tive Oncology Group protocol. J Clin Oncol 1992; 10: 558–563.

    Article  CAS  Google Scholar 

  6. Wardley AM, Jayson GC, Swindell R et al. Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haemopoietic progenitor rescue [in process citation]. Br J Haematol 2000; 110: 292–299.

    Article  CAS  Google Scholar 

  7. Blijlevens NM, Donnelly JP, De Pauw BE . Mucosal barrier injury: biology, pathology, clinical counterparts and consequences of intensive treatment for haematological malignancy: an overview. Bone Marrow Transplant 2000; 25: 1269–1278.

    Article  CAS  Google Scholar 

  8. Rapoport AP, Miller Watelet LF, Linder T et al. Analysis of factors that correlate with mucositis in recipients of autologous and allogeneic stem-cell transplants. J Clin Oncol 1999; 17: 2446–2453.

    Article  CAS  Google Scholar 

  9. Johansson JE, Ekman T . Gastro-intestinal toxicity related to bone marrow transplantation: disruption of the intestinal barrier precedes clinical findings. Bone Marrow Transplant 1997; 19: 921–925.

    Article  CAS  Google Scholar 

  10. Brand RE, DiBaise JK, Quigley EM et al. Gastroparesis as a cause of nausea and vomiting after high-dose chemotherapy and haemopoietic stem-cell transplantation [letter] [see comments]. Lancet 1998; 352: 1985.

    Article  CAS  Google Scholar 

  11. Hecht JR, Lembo T, Chap L . Prolonged nausea and vomiting after high dose chemotherapy and autologous peripheral stem cell transplantation in the treatment of high risk breast carcinoma. Cancer 1997; 79: 1698–1702.

    Article  CAS  Google Scholar 

  12. Eagle DA, Gian V, Lauwers GY et al. Gastroparesis following bone marrow transplantation. Bone Marrow Transplant 2001; 28: 59–62.

    Article  CAS  Google Scholar 

  13. Stotzer PO, Fjalling M, Gretarsdottir J, Abrahamsson H . Assessment of gastric emptying: comparison of solid scintigraphic emptying and emptying of radiopaque markers in patients and healthy subjects. Dig Dis Sci 1999; 44: 729–734.

    Article  CAS  Google Scholar 

  14. Miller AB, Hoogstraten B, Staquet M, Winkler A . Reporting results of cancer treatment. Cancer 1981; 47: 207–214.

    Article  CAS  Google Scholar 

  15. Bjarnason I, Peters TJ, Veall N . A persistent defect in intestinal permeability in coeliac disease demonstrated by a 51Cr-labelled EDTA absorption test. Lancet 1983; 1: 323–325.

    Article  CAS  Google Scholar 

  16. Craig RM, Ehrenpreis ED . D-xylose testing. J Clin Gastroenterol 1999; 29: 143–150.

    Article  CAS  Google Scholar 

  17. Nowak TV, Johnson CP, Kalbfleisch JH et al. Highly variable gastric emptying in patients with insulin dependent diabetes mellitus. Gut 1995; 37: 23–29.

    Article  CAS  Google Scholar 

  18. Wakui M, Okamoto S, Ishida A et al. Prospective evaluation for upper gastrointestinal tract acute graft-versus-host disease after hematopoietic stem cell transplantation. Bone Marrow Transplantation 1999; 23: 573–578.

    Article  CAS  Google Scholar 

  19. Choi MG, Camilleri M, Burton DD et al. [13C]octanoic acid breath test for gastric emptying of solids: accuracy, reproducibility, and comparison with scintigraphy. Gastroenterology 1997; 112: 1155–1162.

    Article  CAS  Google Scholar 

  20. Lee JS, Camilleri M, Zinsmeister AR et al. A valid, accurate, office based non-radioactive test for gastric emptying of solids. Gut 2000; 46: 768–773.

    Article  CAS  Google Scholar 

  21. Feldman M, Smith HJ, Simon TR . Gastric emptying of solid radiopaque markers: studies in healthy subjects and diabetic patients. Gastroenterology 1984; 87: 895–902.

    CAS  PubMed  Google Scholar 

  22. Bertrand J, Metman EH, Dorval ED et al. Étude du temps d'évacuation gastrique de repas normaux au moyen de granules radio-opaques. Applications cliniques et validation. Gastroenterol Clin Biol 1980; 4: 770–776.

    CAS  Google Scholar 

  23. Hermansson G, Sivertsson R . Gender-related differences in gastric emptying rate of solid meals. Dig Dis Sci 1996; 41: 1994–1998.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This study was supported by the Swedish Research Council (Grant no. 13409), by the funds of Jubileumskliniken at Sahlgrenska University Hospital and by the funds of Assar Gabrielsson.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J-E Johansson.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Johansson, JE., Abrahamsson, H. & Ekman, T. Gastric emptying after autologous haemopoietic stem-cell transplantation: a prospective trial. Bone Marrow Transplant 32, 815–819 (2003). https://doi.org/10.1038/sj.bmt.1704234

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1704234

Keywords

This article is cited by

Search

Quick links